The agreement with Pfizer is part of the Trump administration's strategy to implement the 'most favored nation' model, ensuring that the U.S. pays competitive prices for medications. Pfizer will reduce prices on a large scale and will launch the 'TrumpRx' platform for direct sales to patients. Additionally, the company will invest 70 billion dollars in research and production in the U.S.
Sources
Latest News
22:02
Cristela Georgescu accuses the proceedings in Călin Georgescu’s case of irregularities following the extension of his pretrial detention
21:54
Eurostat: Real per capita income rose by 0.1% in the EU in the second quarter of 2026, while the saving rate fell
21:26
MAE warns that transport services in Italy will be affected by a general strike on October 29 and 30
21:02
The Commission is preparing a new SAFE round for all 27 EU member states, including those that did not initially request loans
20:53
The European Commission will assess refineries’ proposals to increase production and is preparing a joint roadmap
See more news